•
•
•
•
•
•
•
•
Country
US
Industry
Health Care
Market Cap
Mid Cap
Num. Employees
2025
IPO Date
Apr 29, 1986
Country
US
Industry
Health Care
Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. The company is headquartered in Waltham, Massachusetts and currently employs 2,025 full-time employees. The firm's bioprocessing business consist of four franchises, filtration; chromatography; process analytics; and proteins. The Filtration products are used in process development and process scale production. The Chromatography franchise includes products used in downstream purification, development, and manufacturing of biological drugs. The Process Analytics products allow end-users to make in-line absorbance measurements allowing for the determination of protein concentration in filtration, chromatography formulation and fill-finish applications. The Proteins franchise is represented by its Protein A affinity ligands, which are a critical component of Protein A chromatography resins used in downstream purification of virtually all monoclonal antibody (mAb) based drugs on the market.
Sources
Mentions
Mentions of this stock across all news source scraped in the past 30 days
Recent Mentions
Recent articles, blogs, and social posts pertaining to this stock
Finnhub
50%
Yahoo
50%
FLUID MANAGEMENT Our market share: ~5% Our 3-year CAGR: ~25% $12B $7.6B Repligen Market Share 2023 TAM ~5% TAM 3-Year Revenue CAGR (2020-2023) Repligen 20% Delivering above industry-average growth, creating new markets, taking share 10 Disclaimer Repligen Corporation published this content on December 05, 2024, and is solely responsible for the information contained herein.
Recent Mentions
Recent Mentions
Recent articles, blogs, and social posts pertaining to this stock
News Sentiment
Sentiment
Composite sentiment (positive vs. negative language) expressed across news sources mentioning this stock
Today
Recent Mentions
Recent articles, blogs, and social posts pertaining to this stock
Slightly Bearish
-31.91% more bearish
compared to last week
Related Stocks
Related Stocks
Stocks being mentioned with RGEN